Ambit Iberia's Blog
Latest Developments in Digital Transformation in the Pharmaceutical, Biotechnology, and Medical Device Sectors
Hybrid Profile: The Importance of Connecting Knowledge
For years, especially in small and medium-sized enterprises, it has been common to find professionals who took on different responsibilities,...
Who codes when AI codes? The new IT profile
La inteligencia artificial está cambiando la manera en la que se desarrolla software, las tecnologías que utilizan los profesionales IT y las...
How to ensure regulatory compliance for your medical device
Developing an innovative medical device is only the first step to reaching the market. To guarantee its commercialization and maintain its conformity...
Rule 11 and AI Act: strategic classification of medical software
The revision of the MDR (Medical Device Regulation) rewrites Rule 11 and the European Artificial Intelligence Act (AI Act) already has a definitive...
From ticket to root cause: how to connect ITSM and ITOM to reduce resolution times
When a user opens a ticket because an application is not responding, the problem may have started much earlier.
In this article, we analyze how the...
Ambit Iberia and Applus+ Laboratories join forces to drive innovation in Life Sciences
“The collaboration combines Ambit Iberia's experience in specialized consulting for Life Sciences with the technical and regulatory capacity of...
Ambit Iberia Receives the Loyalty Partner Award from ManageEngine
At Ambit Iberia, we are proud to have received the Loyalty Award during the ManageEngine Partner Training 2026, an exclusive event for partners held...
How to adapt to regulatory changes in the medical devices sector
The regulatory environment for medical devices is constantly evolving. New regulations, guidelines, standards, and updates from competent authorities...
Partner Insights Magazine 2026: The Present and Future of Life Sciences
At Ambit Iberia, we believe that innovation reaches further when built on collaboration. That is why, once again this year, we are launching Partner...
Ambit Iberia and The Triality Group announce Partnership to accelerate Trusted Artificial Intelligence in Life Sciences
Ambit Iberia, a leading Life Sciences consultancy specializing in Pharma & Biotech, Digital Solutions, and Medical Devices, is proud to announce a...
AI in GxP Environments: The Questions We Can No Longer Put Off
Over the past few years, Artificial Intelligence has moved from being an emerging technology to becoming an increasingly tangible reality in the Life...
Does My Company Need Outsourcing or Can AI Handle It?
Outsourcing or artificial intelligence? Discover in this article when you need external talent, what AI can automate, and why more and more companies...
Clean & Black Utilities in Pharma: Differences for Your GMP Control
In a pharmaceutical manufacturing plant, not everything that sustains production is visible at first glance. Behind every process, auxiliary systems...
ITSM & ITOM Solutions: Strategy and Benefits to Drive Efficiency
In many organizations, the IT department has evolved beyond merely resolving incidents or maintaining operational systems. It is now expected to play...
Ambit Meets 2026: Tech Trends & Compliance in Life Science
Professionals from leading companies across the Life Sciences sector gathered for a new edition of Ambit Meets: Tech trends & Compliance in Life...